Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.44% | -51.19% | -56.85% | -84.97% | 107.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.44% | -51.19% | -56.85% | -84.97% | 107.27% |
| Cost of Revenue | -22.19% | 4.29% | 4.29% | 15.59% | 22.36% |
| Gross Profit | 22.82% | -6.29% | -6.58% | -19.58% | -21.22% |
| SG&A Expenses | -1.31% | 1.49% | 3.66% | 10.38% | 10.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.56% | -12.96% | -3.62% | 9.35% | 16.22% |
| Operating Income | 18.13% | 11.64% | 1.62% | -13.18% | -14.97% |
| Income Before Tax | 7.98% | 15.61% | 18.77% | 4.94% | -2.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.98% | 15.61% | 18.77% | 4.94% | -2.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.98% | 15.61% | 18.77% | 4.94% | -2.20% |
| EBIT | 18.13% | 11.64% | 1.62% | -13.18% | -14.97% |
| EBITDA | 18.12% | 11.57% | 1.35% | -13.72% | -15.57% |
| EPS Basic | 84.51% | 85.53% | 73.35% | 51.13% | 34.84% |
| Normalized Basic EPS | 84.51% | 85.53% | 73.35% | 51.13% | 34.84% |
| EPS Diluted | 84.50% | 85.53% | 73.34% | 51.54% | 35.57% |
| Normalized Diluted EPS | 84.51% | 85.53% | 73.35% | 51.13% | 34.84% |
| Average Basic Shares Outstanding | 352.67% | 480.29% | 373.06% | 241.86% | 129.42% |
| Average Diluted Shares Outstanding | 352.67% | 480.29% | 373.06% | 241.86% | 129.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |